News

Biotech firm can combat EMS, SRS, others with phage technology

DATE: 10th October 2017

By using naturally occurring ‘phages’, company can challenge nearly any bacterial disease impacting the aquaculture industry.

Biotechnology company Fixed Phage has developed a way to tackle prevalent diseases in the aquaculture industry, including Early Mortality Syndrome (EMS) in shrimp and Salmon Rickettsial Syndrome (SRS), its commercial director Athol Haas, told IntraFish.

Read Full Article here:
www.intrafish.com

Related Articles

Pioneering UK biotechnology business, Fixed Phage, has secured additional investment to scale up its fight...
DATE: 15th March 2021

Pioneering UK biotechnology business, Fixed Phage, has secured additional investment to scale up its fight against new microbial threats that pose risks to human health and agricultural production. The company,...

Fixed Phage, (the “Company”) the UK biotechnology company developing and commercialising unique, anti-infective technologies based...
DATE: 26th May 2020

Fixed Phage, (the “Company”) the UK biotechnology company developing and commercialising unique, anti-infective technologies based on bacteriophage immobilisation and stabilisation, today announces the appointment of Dr Gordon Jamieson as Chief...

Carus Animal Health and British biotechnology company, Fixed Phage, have agreed a strategic collaboration in the...
DATE: 23rd March 2020

Carus Animal Health and British biotechnology company, Fixed Phage, have agreed a strategic collaboration in the companion animal field to identify, develop and commercialise stable and specific bacteriophages and their application...